Literature DB >> 23929188

Irreversible electroporation of locally advanced pancreatic head adenocarcinoma.

Robert C G Martin1.   

Abstract

Irreversible electroporation of locally advanced pancreatic adenocarcinoma has been used to palliate appropriate patients with locally advanced pancreatic adenocarcinoma. The setting was at a university tertiary care center. Subjects are patients with locally advanced pancreatic adenocarcinoma who have undergone appropriate induction chemotherapy for at least 3 to 4 months in duration. Technique of open irreversible electroporation of locally advanced pancreatic adenocarcinoma is described. The technique of open irreversible electroporation with continuous intraoperative ultrasound imaging and consideration of intraoperative navigational system is described. Irreversible electroporation of locally advanced pancreatic adenocarcinoma is feasible for locally advanced unresectable pancreatic cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23929188     DOI: 10.1007/s11605-013-2309-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  14 in total

1.  Electrical impedance tomography for imaging tissue electroporation.

Authors:  Rafael V Davalos; David M Otten; Lluis M Mir; Boris Rubinsky
Journal:  IEEE Trans Biomed Eng       Date:  2004-05       Impact factor: 4.538

2.  Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.

Authors:  Robert C G Martin; Kelli McFarland; Susan Ellis; Vic Velanovich
Journal:  J Am Coll Surg       Date:  2012-06-21       Impact factor: 6.113

3.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

4.  In vivo results of a new focal tissue ablation technique: irreversible electroporation.

Authors:  Jon F Edd; Liana Horowitz; Rafael V Davalos; Lluis M Mir; Boris Rubinsky
Journal:  IEEE Trans Biomed Eng       Date:  2006-07       Impact factor: 4.538

5.  Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.

Authors:  Mark P Callery; Kenneth J Chang; Elliot K Fishman; Mark S Talamonti; L William Traverso; David C Linehan
Journal:  Ann Surg Oncol       Date:  2009-04-24       Impact factor: 5.344

6.  Irreversible electroporation of the pancreas: definitive local therapy without systemic effects.

Authors:  Matthew Bower; Leslie Sherwood; Yan Li; Robert Martin
Journal:  J Surg Oncol       Date:  2011-02-28       Impact factor: 3.454

Review 7.  Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.

Authors:  Gauri R Varadhachary; Eric P Tamm; James L Abbruzzese; Henry Q Xiong; Christopher H Crane; Huamin Wang; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans; Robert A Wolff
Journal:  Ann Surg Oncol       Date:  2006-07-24       Impact factor: 5.344

8.  The anatomic location of pancreatic cancer is a prognostic factor for survival.

Authors:  Avo Artinyan; Perry A Soriano; Christina Prendergast; Tracey Low; Joshua D I Ellenhorn; Joseph Kim
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.

Authors:  Robert C G Martin; Kelli McFarland; Susan Ellis; Vic Velanovich
Journal:  Ann Surg Oncol       Date:  2012-11-06       Impact factor: 5.344

10.  Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.

Authors:  Karl Y Bilimoria; David J Bentrem; Ryan P Merkow; James S Tomlinson; Andrew K Stewart; Clifford Y Ko; Mark S Talamonti
Journal:  J Am Coll Surg       Date:  2007-08-03       Impact factor: 6.113

View more
  29 in total

1.  An update on the role of irreversible electroporation in locally advanced pancreatic adenocarcinoma.

Authors:  Robert C G Martin
Journal:  HPB (Oxford)       Date:  2016-08-16       Impact factor: 3.647

2.  Evaluation of a robotic system for irreversible electroporation (IRE) of malignant liver tumors: initial results.

Authors:  L P Beyer; B Pregler; K Michalik; C Niessen; M Dollinger; M Müller; H J Schlitt; C Stroszczynski; P Wiggermann
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-09-21       Impact factor: 2.924

3.  Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer.

Authors:  Mao Lin; Mohammed Alnaggar; Shu-Zhen Liang; Jian Shi; Li-Zhi Niu; Ji-Bing Chen; Ke-Cheng Xu
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

4.  Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.

Authors:  Mao Lin; Shuzhen Liang; Xiaohua Wang; Yinqing Liang; Mingjie Zhang; Jibing Chen; Lizhi Niu; Kecheng Xu
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-04       Impact factor: 4.553

Review 5.  Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer.

Authors:  Salvatore Paiella; Roberto Salvia; Roberto Girelli; Isabella Frigerio; Alessandro Giardino; Mirko D'Onofrio; Giulia De Marchi; Claudio Bassi
Journal:  Updates Surg       Date:  2016-08-18

6.  Irreversible electroporation of locally advanced pancreatic neck/body adenocarcinoma.

Authors:  Robert C G Martin
Journal:  J Gastrointest Oncol       Date:  2015-06

Review 7.  The Landmark Series: Locally Advanced Pancreatic Cancer and Ablative Therapy Options.

Authors:  Rebekah R White; James D Murphy; Robert C G Martin
Journal:  Ann Surg Oncol       Date:  2021-02-14       Impact factor: 5.344

8.  Perioperative systemic immunophenotype following irreversible electroporation (IRE) predicts recurrence.

Authors:  Conor H O'Neill; Min Tan; Jun Yan; Yan Li; Robert C G Martin
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 9.  Irreversible electroporation of stage 3 locally advanced pancreatic cancer: optimal technique and outcomes.

Authors:  Robert C G Martin
Journal:  J Vis Surg       Date:  2015-06-01

10.  Combination of irreversible electroporation with sustained release of a synthetic membranolytic polymer for enhanced cancer cell killing.

Authors:  Samuel M Hanson; Bruce Forsyth; Chun Wang
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.